Product Description
Find answers to common questions about our product, including dosage, storage, and side effects.
- Promacta is indicated for the treatment of thrombocytopenia in patients with chronic immune thrombocytopenia (ITP) who have had an inadequate response to other treatments.
- It is prescribed to help increase platelet counts in patients with ITP, reducing the risk of bleeding episodes and the need for platelet transfusions.
- Promacta may also be used to treat thrombocytopenia in patients with chronic hepatitis C virus (HCV) infection to allow the initiation and maintenance of interferon-based therapy.
- The recommended dosage of Promacta for the treatment of chronic immune thrombocytopenia (ITP) is individualized based on the patient’s platelet count and response to treatment.
- Typically, the initial dosage of Promacta is 50 milligrams (mg) orally once daily.
- The dosage may be adjusted by the healthcare provider based on the patient’s platelet count, with a maximum recommended dosage of 75 mg once daily.
- Promacta should be taken on an empty stomach at least 1 hour before or 2 hours after eating food or consuming dairy products or calcium-fortified beverages.
- Swallow the tablet whole with a glass of water. Do not crush, chew, or break the tablet.
- It is important to take Promacta regularly to achieve and maintain optimal platelet counts.
- If a dose of Promacta is missed, take it as soon as remembered, unless it is almost time for the next scheduled dose. Do not double the dose to catch up.
- If you have any questions or concerns about the dosage or administration of Promacta, consult your healthcare provider.
- Common side effects of Promacta may include headache, fatigue, nausea, and diarrhea.
- Some individuals may experience changes in liver function tests or elevated liver enzymes while taking Promacta.
- Promacta may increase the risk of blood clots, particularly in patients with certain risk factors or at higher dosages.
- Other potential side effects include muscle aches, dizziness, and upper respiratory tract infections.
- In rare cases, Promacta may lead to more serious side effects such as allergic reactions, including rash, itching, or swelling of the face, lips, or tongue.
- Patients should promptly report any unusual or severe side effects to their healthcare provider.
- Inform your healthcare provider about any history of liver disease, blood clots, or bleeding disorders before starting Promacta.
- Use caution when taking Promacta if you have a history of cardiovascular disease or risk factors for blood clots, such as smoking or obesity.
- Discuss with your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding before using Promacta, as it may affect fetal development or breast milk production.
- Be aware that Promacta may interact with other medications, so inform your healthcare provider about all medications you are currently taking, including prescription, over-the-counter, and herbal supplements.
- Regular monitoring of liver function tests, platelet counts, and signs of bleeding or clotting may be necessary while taking Promacta.
- If you experience symptoms such as unusual bruising or bleeding, severe headache, chest pain, or shortness of breath while taking Promacta, seek immediate medical attention.
- Keep Promacta out of reach of children and pets and store it at room temperature away from moisture and heat sources.
| Generic name: | Eltrombopag Olamine |
|---|---|
| Formulation: | Tablet |
| Strength(s): | 25mg, 50mg |
| Quantities Available: | 14, 42 |
Still have a question?
Connect with Our Support Team for Personalized Assistance and Guidance!
